Vasogen Inc (NYSE:MEW - TSE:VAS) Immune Modulation Therapies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasogen Inc (NYSE:MEW - TSE:VAS) Immune Modulation Therapies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Smacs who wrote (7)	1/9/2001 1:54:57 PM
From: tuck	Read Replies (2) of 26

Anybody here? Vasogen becomes a player in the CLL market, which they estimate to be $300 million at present, and which is an area of personal interest. Will be having a closer look . . . biz.yahoo.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next